Monitor trading activity around the new share structure starting April 27, 2026, and assess whether the company meets its contractual obligations under the February 12, 2026 securities purchase agreement.
Price Chart
Executive Summary
Immunic, Inc. (IMUX) announced a 1-for-10 reverse stock split effective April 27, 2026, reducing its outstanding shares from approximately 136 million to 13.6 million. The move is intended to meet contractual obligations under a prior securities purchase agreement.
Key Facts
- Immunic, Inc. executed a 1-for-10 reverse stock split effective April 27, 2026
- Outstanding shares reduced from ~136 million to ~13.6 million
- The reverse split was approved by shareholders on April 14, 2026, and filed with Delaware on April 22, 2026
- The action is primarily intended to meet contractual obligations under a securities purchase agreement dated February 12, 2026
- No fractional shares will be issued; holders of fractional shares will receive cash proceeds from the sale of aggregated shares
Financial Impact
Reduces outstanding shares from ~136 million to ~13.6 million; no change to market cap or authorized shares
Risk Factors
- Potential negative market perception of reverse splits as a sign of financial distress
- Liquidity concerns if trading volume does not adjust proportionally to the reduced share count
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193805-26-000495 |
| Document: e665386_ex99-1.htm | 0001193805-26-000495 |
| Document: e665386_ex3-1.htm | 0001193805-26-000495 |
| Document: 0001193805-26-000495-index-headers.html | 0001193805-26-000495 |
| Document: 0001193805-26-000495-index.html | 0001193805-26-000495 |
| Document: 0001193805-26-000495.txt | 0001193805-26-000495 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 8-K | $12.19 | awaiting T+60 | — | $7.28 (−40.28%) |
Aug 11, 2026 10w ago | 8-K | $15.48 | awaiting T+60 | — | $7.28 (−52.97%) |
Jul 14, 2026 14w ago | 8-K | $14.69 $7.63 | ▼ −48.06% | ▼ −51.44% | $7.28 (−50.44%) |
Jun 29, 2026 17w ago | 8-K | $15.37 $9.37 | ▼ −39.04% | ▼ −42.60% | $7.28 (−52.64%) |
May 19, 2026 22w ago | 3 | $11.55 $16.06 | ▲ +39.05% | ▲ +34.04% | $7.28 (−36.97%) |
May 19, 2026 22w ago | 8-K | $11.60 $16.58 | ▲ +42.93% | ▲ +36.64% | $7.28 (−37.24%) |
Apr 30, 2026 25w ago | S-3/A | $9.65 $13.34 | ▼ −38.24% | ▼ −35.17% | $7.28 (+24.56%) |
Apr 23, 2026 26w ago | 8-K | $9.18 $15.00 | ▲ +63.40% | ▲ +58.38% | $7.28 (−20.70%) |
Apr 14, 2026 27w ago | 8-K | $11.10 $14.77 | ▲ +33.06% | ▲ +24.93% | $7.28 (−34.41%) |
Apr 10, 2026 28w ago | 8-K | $12.20 $14.77 | ▲ +21.07% | ▲ +12.14% | $7.28 (−40.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers